Article
Clinical validation of p16/Ki-67 dual-stained cytology triage of HPV-positive women: Results from the IMPACT trial.
International journal of cancer - 1 Feb 2022
Wright Thomas C, Stoler Mark H, Ranger-Moore Jim, Fang Qijun, Volkir Patrick, Safaeian Mahboobeh, Ridder Ruediger
Abstract excerpt
Triage strategies are needed for primary human papillomavirus (HPV)-based cervical cancer screening to identify women requiring colposcopy/biopsy. We assessed the performance of p16/Ki-67 dual-stained (DS) immunocytochemistry to triage HPV-positive women and compared it to cytology, with or without HPV16/18 genotyping. A prospective observational screening study enrolled 35 263 women aged 25 to 65 years at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
